Concepedia

Tatjana Schmitz

TS

Statistics

Publications

3

Citations

222

H-Index

3

Active since

2017

Affiliations

University of Freiburg(Current)

UNSW Sydney

University Medical Center Freiburg

Heidelberg University

St Vincent's Clinic

Tatjana Schmitz is an author at University of Freiburg specializing in molecular oncology, oncology, and medicine.

Publications per year

2017–2023

3

Publications

3

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

Jessica L. Chitty, Michelle Yam, Lara Perryman et al. · Nature Cancer · 2023 · 124 citations · Full text

, , +13

The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive Behavior

Florian Weinberg, Nadine Reischmann, Lisa Fauth et al. · EBioMedicine · 2017 · 50 citations · Full text

, , +17

<scp>ADAM</scp>9 contributes to vascular invasion in pancreatic ductal adenocarcinoma

Victor Oginga Oria, Paul Lopatta, Tatjana Schmitz et al. · Molecular Oncology · 2018 · 48 citations · Full text

, , +16

1–3 of 3